Capital Markets
Company Overview of Care Capital, LLC
Company Overview
Care Capital, LLC is a venture capital firm specializing in investments in later stage companies. It prefers to invest in companies that are developing pre-clinical or early clinical pharmaceutical assets. The firm considers investment in life science companies with a focus on pharmaceuticals and biotechnology enterprises. It typically invests between $5 million and $20 million in its portfolio companies. Care Capital, LLC was founded in September 2000 and is based in Princeton, New Jersey.
47 Hulfish Street
Suite 310
Princeton, NJ 08542
United States
Founded in 2000
Key Executives for Care Capital, LLC
Care Capital, LLC Key Developments
Eli Lilly & Co. announced that it has signed agreements with private investors Care Capital, LLC and NovaQuest Capital Management, L.L.C. to establish BioCritica Inc., a newly-formed and privately-held biotechnology company. BioCritica, based in Central Indiana, will initially focus on the continued U.S. development and commercialization of Xigris(R) (drotrecogin alfa (activated)), Lilly's medicine for severe sepsis. BioCritica intends to ultimately build a broad portfolio of innovative, hospital-based critical care medicines. As part of a licensing agreement, BioCritica will acquire the U.S. development and commercialization rights to Xigris and will also receive the rights to potentially acquire several critical care compounds currently in pre-clinical development at Lilly. The collaboration also includes a supply agreement, a services agreement and an option for BioCritica to potentially acquire the development and commercialization rights to Xigris outside the U.S. at a later date. In return, Lilly will receive royalties on future U.S. sales of Xigris and will also receive an equity stake in BioCritica. Specific financial terms of the transaction are not being disclosed. The creation of BioCritica received the support of the Indiana Economic Development Corporation (IEDC) and BioCrossroads, Indiana's public-private initiative to grow, advance and invest in the life sciences. BioCritica's formation and the Lilly-BioCritica collaboration are the latest successes in the state's efforts to attract new life sciences companies to Central Indiana.
Similar Private Companies By Industry
| Company Name | Region |
| Blizzard Management, LLC | United States |
| Aurora Schools Federal Credit Union | United States |
| Agra, Gill and Duffus, Inc. | United States |
| Blc Financial Services, Inc. (Illinois) | United States |
| Self Reliance Baltimore Federal Credit Union | United States |
Recent Private Companies Transactions
| Type Date |
Target |
|
Merger/Acquisition
August 30, 2012 |
Sunovion Respiratory Development Inc. |
|
Private Placement
July 18, 2012 |
Agile Therapeutics, Inc. |
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- New York, NY | CapgeminiPosted: May 17
- New York, NY | DeloittePosted: May 12
- New York, NY | Network Esc (a Division of Network Temps, Inc.)Posted: May 17
- Chicago, IL | Jones Lang LaSallePosted: May 14
Sponsored Financial Commentaries
Sponsored Links
To contact Care Capital, LLC, please visit www.carecapital.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








